Biosimilar Contract Manufacturing Market Analysis: Emerging Technologies and Forecast
The Biosimilar Contract Manufacturing Market is expanding through investments in manufacturing capacity and international outsourcing partnerships. North America held more than 45% of the global market in 2024, while Europe accounted for approximately 30%. Asia-Pacific is emerging as a particularly attractive manufacturing region because of competitive production costs, expanding...
0 Comments 0 Shares 64 Views 0 Reviews